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Abstract
Introduction In the western world, cannabis is the most
widely used drug of abuse. Cannabinoid hyperemesis
syndrome, which seems to be a rare paradoxical reaction in
individuals with a particular predisposition, is character-
ized by cyclic severe nausea and vomiting in long-term
cannabis users. While the symptoms are unresponsive to
antiemetic drugs, compulsive hot baths result in a consid-
erable symptom relief.
Methods We report the first case of cannabinoid hyper-
emesis syndrome in pregnancy. A 26-year-old patient was
admitted to our clinic in the 10th week of gestation.
Conclusion Before undertaking time-consuming and exp-
ensive medical examinations to rule out other medical reasons
for therapy-resistant hyperemesis in pregnancy, obstetricians
should determine whether compulsive bathing or showering
provides symptomatic relief and ask specific questions
regarding possible/suspected cannabis consumption.
Keywords Cannabis  Hyperemesis  Pregnancy 
Vomiting
Introduction
In the Western world, cannabis is the most widely used
illicit dependence causing substance and after the legal
drugs tobacco and alcohol the third most commonly used
one. In Europe, the prevalence of cannabis use among
young adults has increased from an average of 5% in 1990
to 15% in 2005 [1]. According to estimates, approximately
3–10% of pregnant women regularly consume cannabis
[2].
In 2004, Allen et al. [3] first described a cannabinoid
hyperemesis syndrome (CHS). The clinical symptoms
include cyclical vomiting patterns. We report the first case
to our knowledge of this entity in pregnancy. We discuss
this syndrome in the particular context of pregnancy and
hope to increase the awareness of the obstetricians of this
unusual and underreported situation.
Case report
A 26-year-old Caucasian woman presented to the Univer-
sity Women’s Hospital Basel (Basel, Switzerland) in the
10th week of gestation with nausea and vomiting for
the past 24 h. On admission, the patient reported a prior
hospitalization 4 months ago in the general emergency
department due to gastritis-like symptoms with nausea and
vomiting. The further medical history revealed an earlier
termination of pregnancy 7 years ago and knee surgery
3 years ago. Except for smoking five cigarettes a day, she
reported no drug use or medication intake.
Transvaginal sonography showed a singleton pregnancy
consistent with 10 gestational weeks. The ovaries were
unremarkable. Hyperemesis gravidarum was assumed and
the standard laboratory workup of urine and blood samples
was performed. The only abnormal parameter was signifi-
cant ketonuria. A normal thyroid-stimulating hormone
(TSH) level excluded primary or pregnancy-induced
hyperthyroidism.
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During the first days of the inpatient stay, the patient
suffered from frequent and severe vomiting episodes (up to
12 times a day) and nearly constant nausea. The symptoms
were resistant to the administration of vitamin B6, meto-
clopramide, chlorazine, dexamethasone and ondansetron.
Dehydration was treated by intravenous fluid replacement.
On the second day of hospitalization, the medical staff
noted that the patient showered more than once a day and
her constitution and mood seemed to considerably improve
during and shortly after showering. Because of this addi-
tional information, we began to consider CHS. After spe-
cific inquiry, the patient admitted to regular daily use of
cannabis since the age of 13. She had only stopped
smoking cannabis after learning about her pregnancy,
which was about 10 days before the onset of the current
symptoms. The subsequently conducted urine drug screen
was positive for cannabis, but not for any other drug. With
the presumptive diagnosis of CHS, we suggested taking hot
baths and showers. With these measures, her symptoms
improved considerably and we stopped all antiemetic
medication. The patient was discharged a day later and was
afterwards regularly seen in our outpatient clinic. She
continued taking hot baths and showers up to five times a
day, which led to a massive improvement of her symptoms
and the recovery of her appetite. Two weeks later, all
symptoms were resolved.
Looking back, the patient reported that she had experi-
enced recurrent episodes (about twice a year) of nausea and
vomiting over the last 3.5 years without having altered her
cannabis consumption. She was even once hospitalized in
the psychiatric clinic due to vomiting which was considered
psychogenic. During one of these first episodes she expe-
rienced improvement of her symptoms during and after
taking hot showers or baths. Having stopped cannabis use
immediately after learning about her early pregnancy and
knowing of the high frequency of morning sickness in
pregnancy, it did not occur to the patient that there could be
a connection between the actual symptoms and the ones she
repetitively experienced over the previous years. Over time
the patient stayed abstinent and remained symptom free.
The pregnancy progressed without further complications.
Comment
Since there are no larger scale systematic analyses of CHS
to date, the typical clinical features for this syndrome were
established based on isolated case reports published in the
last 7 years [3–14] (Table 1). After regular cannabis use
for several years, the patients develop severe nausea and
vomiting, often accompanied by colicky abdominal pain
without an obvious organic cause; this recurs in a cyclic
pattern over months. While the symptoms are unresponsive
to the common antiemetic drugs, taking hot baths or
showers improves the condition. Acquired compulsive
bathing behavior, a result of this unconventional ‘‘ther-
apy’’, is thus a notable characteristic of CHS. Normally, the
symptoms resolve in 24–48 h with conservative manage-
ment and cessation of cannabis use. As described in our
case, the symptoms may also occur after several days to a
few weeks of cannabis abstinence.
Since cannabis is known to have an antiemetic effect
which can be particularly useful in the treatment of cancer
patients [15], CHS seems to be a rare paradoxical reaction
in individuals with a particular predisposition. The mech-
anism of CHS is unknown. Theories attempting to explain
both the symptoms and the effectiveness of the unusual
bathing ‘‘therapy’’, include dose-dependent build-up of
cannabinoids and effects of agent-related toxicity, as well
as alterations of cannabinoid receptors in the brain, in
particular, in the hypothalamus which regulates thermo-
regulation and autonomic equilibrium via the limbic sys-
tem [3, 7, 12].
Previously published case reports regarding CHS come
exclusively from internal medicine/gastroenterology [3–12,
14] or psychiatry/addiction medicine [13]. We present the
first case of this entity in connection with pregnancy.
Compared to the above-mentioned medical subspecialities,
there are relevant differences in obstetrics:
– In gastroenterology and particularly in psychiatry/
addiction medicine, the intake of illicit drugs is often
frankly reported by the patients, which is not always the
case in obstetrics. The hazards of drug abuse in
pregnancy are widely known [16]. Although moderate
drug use is not only accepted, but even in vogue in
some social circles, drug abuse during pregnancy is
objectionable. This may lead to pregnant patients
intentionally concealing their drug consumption to
avoid uncomfortable situations. One should be aware
that overtly critical or hostile behavior of the medical
Table 1 Diagnostic features of cannabinoid hyperemesis syndrome
(modified from [12])
Essential precondition
History of regular cannabis use for years
Clinical features
Severe nausea and vomiting, unresponsive to antiemetic agents
Vomiting, often accompanied by colicky abdominal pain that
recurs in a cyclic pattern of months
Compulsive hot baths/showers with considerable symptom relief
No evidence of other underlying gastrointestinal (e.g. gall bladder
or pancreatic inflammation), genitourinary, metabolic or
neurological diseases which could cause similar clinical
symptoms
Resolution of symptoms after stopping cannabis use
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staff towards pregnant drug users may act as a barrier to
compliance with surveillance and treatment. Further-
more, some patients may not associate their complaints
with illicit drug use, as in the case presented here, and
feel that consumption does not need to be mentioned at
all.
– Particularly in early pregnancy, hyperemesis gravida-
rum is a much more common and plausible diagnosis
for excessive nausea and vomiting. However, resistance
to antiemetic therapy is suspicious for CHS: while
hyperemesis gravidarum usually responds to medical
therapy (nonpharmacologic and antiemetic drugs such
as H1 blockers, dopamine antagonists, phenothiazines,
5-HT3 receptor agonists and steroids) [17], administra-
tion of these agents does not lead to symptomatic relief
in patients with CHS.
Therefore, before undertaking time-consuming and
expensive medical examinations to rule out other medical
reasons for therapy-resistant hyperemesis (e.g., gastroin-
testinal and genitourinary conditions, metabolic and neu-
rologic disorders) [17], obstetricians should perform the
following:
1. Determine whether compulsive bathing provides symp-
tomatic relief (pathognomonic feature of CHS).
2. Ask specific questions regarding possible/suspected
cannabis consumption.
Should the patient admit to drug abuse, an interdisci-
plinary approach to the problem, including the involvement
of experienced drug counselors, should be immediately
undertaken.
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